Cargando…
Botanical drug clinical trial: Common issues and future options
In order to understand this disparity between human use and drugs approved by regulatory agencies, we analyzed botanical drug clinical trials registered at ClinicalTrial.gov to detect trends in current trials and guide future trials. A total of 195 botanical drug clinical trials were registered from...
Autores principales: | Sun, Yu, Qian, Jiahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438343/ https://www.ncbi.nlm.nih.gov/pubmed/32839685 http://dx.doi.org/10.1016/j.apsb.2020.08.003 |
Ejemplares similares
-
What Is the Future for Global Case Management Guidelines for Common Childhood Diseases?
por: English, Mike, et al.
Publicado: (2008) -
Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola
por: Gostin, Lawrence O., et al.
Publicado: (2016) -
Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries
por: Schluger, Neil, et al.
Publicado: (2007) -
Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
por: Kesselheim, Aaron S., et al.
Publicado: (2017) -
Revisiting the Design of Phase III Clinical Trials of Antimalarial Drugs for Uncomplicated Plasmodium falciparum Malaria
por: Borrmann, Steffen, et al.
Publicado: (2008)